Company Financials: Dyax Corporation

• Publication date: January 2010

Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. THIS PRODUCT HAS BEEN DESIGNED FOR DELIVERY IN A DATAPACK FORMAT (.XLS). PLEASE SELECT THE DATAPACK OPTION FROM THE DOWNLOAD MENU. Scope...

Introduction

The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. THIS PRODUCT HAS BEEN DESIGNED FOR DELIVERY IN A DATAPACK FORMAT (.XLS). PLEASE SELECT THE DATAPACK OPTION FROM THE DOWNLOAD MENU.

Scope

*Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation

*Provides key ratios

*Includes information on revenue distribution by business segments and geographies

Highlights

Dyax, a development stage biopharmaceutical company, is focused on developing and commercializing products for inflammatory and oncology indications. The company, through its proprietary drug discovery technology, known as phage display, identifies antibody, small protein and peptide compounds for clinical development.

Dyax's Kalbitor (ecallantide) is approved for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older.

Reasons to Purchase

*Access important financial information and analysis on the company in a single datapack

*Understand the financial evolution of the five company over the last years.

*Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization

Healthcare Industry in the United States

Healthcare in United States

United States Births Per `000 Population

• $ 250
• Industry data
• January 2013

Yearly, From 2004 To 2014
By Business Monitor International
Source: FedStats, Department of Health, World Health Organization (WHO),BMI

• Industries : Healthcare
• Countries : United States

United States Deaths Per `000 Population

• $ 250
• Industry data
• January 2013

Yearly, From 2004 To 2014
By Business Monitor International
Source: FedStats, Department of Health, World Health Organization (WHO),BMI

• Industries : Healthcare
• Countries : United States